Renoprotective effects of cardiotrophin‐1 in a mouse model of chronic kidney disease

Madsen, Kirsten

doi:10.1111/apha.13274

Cited by 1 publication

(1 citation statement)

References 6 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While CT-1 generally promotes cell survival, its prolonged overexpression can lead to worsened cardiac hypertrophy and fibrosis [ 142 ]. The effect of CT-1 on renal tissue is debated; initially thought to mediate renal fibrosis [ 143 ], recent studies suggest it may protect against renal damage in certain models of kidney obstruction [ 144 , 145 ].…”

Section: Cardiorenal Butterfly Effectmentioning

confidence: 99%

Unraveling Chronic Cardiovascular and Kidney Disorder through the Butterfly Effect

Bedo,

Beaudrey,

Florens

2024

Diagnostics

View full text Add to dashboard Cite

Chronic Cardiovascular and Kidney Disorder (CCKD) represents a growing challenge in healthcare, characterized by the complex interplay between heart and kidney diseases. This manuscript delves into the “butterfly effect” in CCKD, a phenomenon in which acute injuries in one organ lead to progressive dysfunction in the other. Through extensive review, we explore the pathophysiology underlying this effect, emphasizing the roles of acute kidney injury (AKI) and heart failure (HF) in exacerbating each other. We highlight emerging therapies, such as renin–angiotensin–aldosterone system (RAAS) inhibitors, SGLT2 inhibitors, and GLP1 agonists, that show promise in mitigating the progression of CCKD. Additionally, we discuss novel therapeutic targets, including Galectin-3 inhibition and IL33/ST2 pathway modulation, and their potential in altering the course of CCKD. Our comprehensive analysis underscores the importance of recognizing and treating the intertwined nature of cardiac and renal dysfunctions, paving the way for more effective management strategies for this multifaceted syndrome.

show abstract